Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Trends in the incidence and treatment of parathyroid cancer in the United States.Cancer. 2007; 109: 1736-1741
- Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.Surgery. 2014; 156 (discussion 1629-30): 1622-1629
- Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort.J Cancer Res Clin Oncol. 2021; 147: 3091-3097
- Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma.Ann Surg Oncol. 2018; 25: 2535-2540
- Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB).Ann Of Surg Oncol. 2015; 22: 3990-3995
- Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.J Of Clin Endocrinol And Metab. 2009; 94: 335-339
- Parathyroid Carcinoma: Diagnosis and Clinical Implications.Turk Patoloji Derg. 2015; 31: 80-97
- Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.Ann Of Surg Oncol. 2019; 26: 3593-3599
- Contemporary Evaluation and Management of Parathyroid Carcinoma.JCO Oncol Pract. 2020; (JOP1900540)https://doi.org/10.1200/JOP.19.00540
- Diagnosis and Surgical Management of Parathyroid Carcinoma.in: Shifrin A.L. Raffaelli M. Randolph G.W. Endocrine surgery comprehensive board exam guide. Springer International Publishing, 2021: 379-403
- Overview of the 2022 WHO Classification of Parathyroid Tumors.Endocr Pathol. 2022; 33: 64-89
- Parathyroid carcinoma.Best Pract Res Clin Endocrinol Metab. 2018; 32: 877-889
- Prognostic factors in parathyroid cancer: a review of 95 cases.World J Surg. 1992; 16: 724-731
- Clinical review 122: Parathyroid carcinoma.J Of Clin Endocrinol And Metab. 2001; 86: 485-493
- Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes.Ear Nose Throat J. 2004; 83: 491-494
- Clinical presentation, staging and long-term evolution of parathyroid cancer.Ann Surg Oncol. 2010; 17: 2156-2174
- Parathyroid carcinoma: a 43-year outcome and survival analysis.J Of Clin Endocrinol And Metab. 2011; 96: 3679-3686
- Parathyroid carcinoma.Surg Oncol. 2014; 23: 107-114
- Oncologic progress for the treatment of parathyroid carcinoma is needed.J Surg Oncol. 2016; https://doi.org/10.1002/jso.24407
- The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.CA Cancer J Clin. 2017; 67: 93-99
- Parathyroid carcinoma: a diagnostic and therapeutic challenge.Cancer. 1999; 86: 378-380
- Classification of parathyroid cancer.Ann Surg Oncol. 2012; 19: 2620-2628
- Current and future treatments for parathyroid carcinoma.Int J Endocr Oncol. 2018; https://doi.org/10.2217/ije-2017-0011
- AJCC cancer staging manual.8th edition. Springer, Cham2017
- Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data.Clin Endocrinol. 2020; 92: 295-302
- Local resection versus radical surgery for parathyroid carcinoma: a national cancer database analysis.Eur J Of Surg Oncol. 2021; 47: 2768-2773
- Prognostic Analysis for Patients With Parathyroid Carcinoma: A Population-Based Study.Front Neurosci. 2022; 16: 784599
- Parathyroid carcinoma: incidence, survival analysis, and management: a study from the seer database and insights into future therapeutic perspectives.Cancers (Basel). 2022; 14https://doi.org/10.3390/cancers14061426
- A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study.Front Endocrinol. 2022; 13: 850457
- Definition and assessment of frailty in older patients: the surgical, anaesthesiological and oncological perspective.Ecancermedicalscience. 2020; 14: 1105
- The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute.Endocr Pract. 2019; 25: 634-641
- Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases.Oncol Lett. 2017; 14: 7276-7282
- Is central lymph node dissection necessary for parathyroid carcinoma?.Surgery. 2014; 156 (discussion 1341): 1336-1341
- Prognostic scoring system to risk stratify parathyroid carcinoma.J Am Coll Surg. 2017; https://doi.org/10.1016/j.jamcollsurg.2017.01.060
- Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients.Clin Endocrinol. 2016; https://doi.org/10.1111/cen.13055
- Parathyroid hormone levels predict long-term outcome after operative management of parathyroid cancer.Horm Metab Res. 2017; 49: 485-492
- Tumor size rather than the thyroid invasion affects the prognosis of parathyroid carcinoma without lymph node or distant metastasis.Eur Arch oto-rhino-laryngology. 2022; https://doi.org/10.1007/s00405-022-07403-w
- Extended En bloc reoperation for recurrent or persistent parathyroid carcinoma: analysis of 31 cases in a single institute experience.Ann Surg Oncol. 2022; 29: 1208-1215
- Tumors of the parathyroid glands.in: R Lloyd R. Osamura G. Kloppel J.R. In WHO classification of tumors of endocrine organs. IARC Press, 2017: 145-159
- Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study.Surgery. 2014; 156: 1132-1144
- Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society.Cancer. 1999; 86: 538-544
- Lymph node involvement and surgical approach in parathyroid cancer.World J Surg. 2010; 34: 2611-2620
- Current concepts in parathyroid carcinoma: a single Centre experience.BMC Endocr Disord. 2019; 19: 46
- Clinical Course of Metastatic Parathyroid Cancer.World J Surg. 1994; 18: 594-599
- Mortality factors in recurrent parathyroid cancer: a pooled analysis.J Bone Miner Metab. 2022; 40: 508-517
- Understanding the genetic basis of parathyroid carcinoma.Endocr Pathol. 2014; 25: 30-34
- Parathyroid carcinoma: Challenges in diagnosis and treatment.Ann Endocrinol (Paris). 2015; 76: 169-177
- CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.Endocr Connect. 2013; 2: 186-195
- A nationwide study on parathyroid carcinoma.Acta Oncol. 2017; 56: 991-1003
- CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.Cell Oncol (Dordr). 2012; 35: 411-422
- Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas.PloS one. 2012; 7: e45567
- Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma.Mod Pathol. 2011; 24: 688-697
- Immunocyte density in parathyroid carcinoma is correlated with disease relapse.J endocrinological Invest. 2020; https://doi.org/10.1007/s40618-020-01224-6
- Parathyroid Carcinoma.Front Horm Res. 2019; 51: 63-76
- Hereditary endocrine tumours: current state-of-the-art and research opportunities: new and future perspectives for parathyroid carcinoma.Endocr Relat Cancer. 2020; 27: T53-T63
- Parathyroid carcinoma: a review.Indian J Surg Oncol. 2022; 13: 133-142
- Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years.Pract Radiat Oncol. 2017; 7: e463-e470
- The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a national cancer database analysis.Ann Surg Oncol. 2020; https://doi.org/10.1245/s10434-020-08825-8
- Parathyroid cancer: An update.Cancer Treat Rev. 2020; 86: 102012
- Parathyroid Cancer: A Review.Cancers (Basel). 2019; 11https://doi.org/10.3390/cancers11111676
- Sorafenib treatment improves refractory hypercalcemia in a patient with metastatic parathyroid carcinoma: a case report. Endocr Soc Poster presented at: 2014; 2014; Chicago.(Available at:) (Accessed July 15, 2022)
- Metastatic parathyroid carcinoma and hypercalcemia responds to treatment with sorafenib. Endocr Soc Poster presented at: 2014; 2014; Chicago.(Available at:) (Accessed July 15, 2022)
- Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases.Endocrinol Diabetes Metab Case Rep. 2017; 2017https://doi.org/10.1530/EDM-16-0113
- The clinicopathological spectrum of parathyroid carcinoma.Front Endocrinol. 2019; 10: 731
- The status of tumor mutational burden and immunotherapy.Nat Cancer. 2022; 3: 652-656
- Classifying cancers based on T-cell Infiltration and PD-L1.Cancer Res. 2015; 75: 2139-2145
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors.Nat Rev Clin Oncol. 2021; 18: 345-362
- Clinical significance of Pd-L1 expression in parathyroid cancer.Acta Endocrinol (Buchar). 2016; 12: 383-386
- Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.Surgery. 2018; https://doi.org/10.1016/j.surg.2018.06.013
- Biomarkers for immunotherapy: current developments and challenges.Am Soc Clin Oncol Educ Book. 2016; 35: e493-e503
- Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy.Oncologist. 2019; 24: 791-797
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Science. 2017; 357: 409-413
- Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab.BMJ case Rep. 2020; 13https://doi.org/10.1136/bcr-2020-235293
- Genomic profiling reveals mutational landscape in parathyroid carcinomas.JCI Insight. 2017; 2: e92061
- Complete genomic landscape of a recurring sporadic parathyroid carcinoma.J Pathol. 2013; 230: 249-260
- Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways.J Endocr Soc. 2019; 3: 544-559
- Genetic profiling as a clinical tool in advanced parathyroid carcinoma.J Cancer Res Clin Oncol. 2019; 145: 1977-1986
- Targeting mutations in cancer.J Clin Invest. 2022; 132https://doi.org/10.1172/JCI154943
- Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma.Eur Urol. 2017; 71: 405-414
- Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.Int J Cancer. 2019; 144: 525-532
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
